These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 324478)

  • 1. Studies on the mutagenicity of nitrofurans in Salmonella typhimurium.
    Rosenkranz HS
    Biochem Pharmacol; 1977 May; 26(9):896-8. PubMed ID: 324478
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic activity of carcinogenic and noncarcinogenic nitrofurans and of urine of rats fed these compounds.
    Wang CY; Lee LH
    Chem Biol Interact; 1976 Sep; 15(1):69-75. PubMed ID: 786488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of nitrofurans, nitrothiophenes, nitropyrroles, nitroimidazole, aminothiophenes, and aminothiazoles in Salmonella typhimurium.
    Wang CY; Muraoka K; Bryan GT
    Cancer Res; 1975 Dec; 35(12):3611-7. PubMed ID: 1104157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity studies with nitrofurans. III. Mutagenicity testing of nitrofurylacrylic acid in human blood and urine.
    Cerná M; Rössner P; Angelis K; Nováková J; Srám RJ
    Mutat Res; 1980 Jan; 77(1):13-20. PubMed ID: 6987508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity studies with nitrofurans. II. mutagenicity of nitrofurylacrylic acid for Salmonella typhimurium.
    Cerná M; Srám RJ
    Mutat Res; 1980 Jan; 77(1):1-12. PubMed ID: 6987507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98.
    Chin JB; Sheinin DM; Rauth AM
    Mutat Res; 1978 Sep; 58(1):1-10. PubMed ID: 362190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between the carcinogenic and mutagenic or DNA-modifying effects of nitrofuran derivatives, including 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide, a food additive.
    Yahagi T; Nagao M; Hara K; Matsushima T; Sugimura T; Bryan GT
    Cancer Res; 1974 Sep; 34(9):2266-73. PubMed ID: 4602893
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenicity of nitrovin--a nitrofuran feed additive.
    Joner PE; Dahle HK; Aune T; Dybing E
    Mutat Res; 1977 Jul; 48(3-4):313-8. PubMed ID: 327315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagen screening with bacteria: niridazole and nitrofurans.
    McCalla DR; Voutsinos D; Olive PL
    Mutat Res; 1975 Feb; 31(1):31-7. PubMed ID: 1093013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic evaluation of nitrofuran derivatives in Salmonella typhimurium, by the micronucleus test, and by in vivo cytogenetics.
    Goodman DR; Hakkinen PJ; Nemenzo JH; Vore M
    Mutat Res; 1977 Jul; 48(3-4):295-305. PubMed ID: 327313
    [No Abstract]   [Full Text] [Related]  

  • 11. First characterization of the mutagenic specificity of 7-methoxy-2-nitronaphtho[2,1-b]furan (R7000) in Salmonella typhimurium.
    Quillardet P; Touati E; Hofnung M
    Mutat Res; 1991 May; 248(1):85-92. PubMed ID: 2030714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids.
    McCann J; Spingarn NE; Kobori J; Ames BN
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):979-83. PubMed ID: 165497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative relationships between lipophilicity and mutagenic effects of N-substituted amides of 3-(5-nitro-2-furyl)-acrylic acid on Salmonella typhimurium.
    Baláz S; Sturdík E; Dibus I; Ebringer L; Stibrányi L; Rosenberg M
    Chem Biol Interact; 1985 Oct; 55(1-2):93-108. PubMed ID: 3905031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutagenicity for Salmonella typhimurium (Ames test) of some trichomonacides].
    Tamaro M; Baraggino E; Pilotto A
    Minerva Ginecol; 1979 Apr; 31(4):263-72. PubMed ID: 379709
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutagenic activity, antibacterial activity and enzymatic reducibility of geometrical isomers of nitrofurans in Salmonella typhimurium TA100.
    Kato Y; Ogawa H; Tadakuma K; Kakimoto K; Tsuruta S; Kitamura S; Tatsumi K
    Chem Pharm Bull (Tokyo); 1984 May; 32(5):2036-9. PubMed ID: 6380782
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutagenicity of N-nitrosopiperazines for Salmonella typhimurium in the host-mediated assay.
    Zeiger E; Legator MS; Lijinsky W
    Cancer Res; 1972 Jul; 32(7):1598-9. PubMed ID: 4555385
    [No Abstract]   [Full Text] [Related]  

  • 17. [The new SOS chromotest (CEA test) for demonstrating mutagens and promutagens based on the indicator strain Salmonella typhimurium TA1535].
    Egorov IA; Svistunova GL; Darkazanli K; Kalinina LM; Tarasov VA
    Dokl Akad Nauk SSSR; 1991; 318(5):1230-2. PubMed ID: 1914822
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a simplified fluctuation test to detect and characterize mutagenesis by nitrofurans.
    Green MH; Rogers AM; Muriel WJ; Ward AC; McCalla DR
    Mutat Res; 1977 Jul; 44(1):139-43. PubMed ID: 331096
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimutagenic properties of lactic acid-cultured milk on chemical and fecal mutagens.
    Hosono A; Kashina T; Kada T
    J Dairy Sci; 1986 Sep; 69(9):2237-42. PubMed ID: 3097092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium.
    Ueno Y; Kubota K; Ito T; Nakamura Y
    Cancer Res; 1978 Mar; 38(3):536-42. PubMed ID: 342092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.